Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic
  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Church & Dwight Reports Q1 2024 Results

2024 First Quarter Results

  • Net Sales +5.1%: Domestic +4.3%, Int’l +10.6%, SPD +1.0%
  • Organic Sales¹ +5.2%: Domestic +4.3%, Int’l +8.8%, SPD +7.2%
  • Gross Margin +220 bps
  • Reported EPS $0.93, Adjusted EPS $0.96¹
  • Cash from Operations of $263 million

2024 Full Year Outlook

  • Net Sales +4% to 5%; Organic Sales +4% to 5%¹
  • Gross Margin expansion raised to +75 bps
  • Reported EPS +9.5-10.5%
  • Adjusted EPS raised to +8-9%¹
  • Cash from Operations ~$1.05 billion

Church & Dwight Co., Inc. (NYSE: CHD) today announced the Company exceeded its outlook with stronger than expected sales growth and gross margin expansion. In the first quarter, net sales grew 5.1% to $1,503.3 million, gross margin expanded by 220 basis points, and reported EPS grew 13.4%. The Company continues to drive strong consumer demand across its portfolio. Organic sales grew 5.2% driven by volume of 3.7% and positive product mix and pricing of 1.5%.

First quarter 2024 Reported EPS was $0.93; an increase of 13.4% compared to 2023 reported EPS. First quarter Adjusted EPS was $0.96; an increase of 12.9%. First quarter Adjusted EPS exceeded the Company’s outlook of $0.85 driven by higher-than-expected sales growth and gross margin expansion, and a lower tax rate.

Matthew Farrell, Chief Executive Officer, commented, “The Company is performing extremely well with all three divisions delivering strong growth. I want to thank our global employees for their great efforts each and every day. Our outstanding Q1 results reflect the strength of our brands, the early success of our new products, and our perennial focus on execution. Volume was the primary driver of organic growth, and we expect volume growth to continue for the rest of the year. Marketing as a percent of sales increased 150 bps driving strong consumption and share gains. Global online sales grew to 20.5% of total consumer sales in Q1, a dollar increase of 14.9% compared to Q1 2023. Finally, the combination of strong sales, margin expansion, and efficient working capital management resulted in strong cash flow generation in the first quarter, leading to over $1 billion of cash from operations expected in the full year outlook.

“Organic revenue growth was broad-based as all three businesses posted exceptional results. The Domestic Division grew 4.3% organically while growing share in five of our seven power brands. The International Division grew 8.8% organically, driven by growth in all of our country subsidiaries and our Global Markets Group. Our Specialty Products Division grew organic revenue 7.2% led by global expansion of the non-dairy portfolio.

“In March, we signed a definitive agreement to acquire Graphico, our Japan based distributor, for approximately $35 million including transaction costs. We expect the acquisition to close later this year. Since 2008, Graphico has partnered with Church & Dwight and driven Oxiclean to be the #1 powder prewash additive in Japan. The acquisition is expected to contribute to greater expansion of our business in Japan and the greater APAC region as we leverage the capabilities of Graphico in bringing the larger portfolio of Church & Dwight brands to Japanese consumers.

First Quarter Review

Consumer Domestic net sales were $1,165.2 million, a $48.3 million or 4.3% increase driven by both household and personal care sales growth. Organic sales increased 4.3% due to volume (+3.3%) and price and product mix (+1.0%). Growth was led by THERABREATH™ mouthwash, HERO™ acne products, ARM & HAMMER™ Cat Litter, ARM & HAMMER™ Baking Soda, XTRA™ Liquid Detergent, and BATISTE™ dry shampoo, partially offset by declines in the vitamin business and WATERPIK™.

Consumer International net sales were $255.0 million, a $24.4 million or 10.6% increase. Organic sales increased 8.8% due to a combination of higher volume (+5.4%) and price and product mix (+3.4%). Growth was led by STERIMAR™, HERO and THERABREATH.

Specialty Products net sales were $83.1 million, a $0.8 million or 1.0% increase including the impact of winding down the Megalac business. Organic sales increased 7.2% due to higher price and product mix (+4.2%) and volume (+3.0%).

Gross margin increased 220 basis points to 45.7% due to improved productivity, volume, mix and pricing, net of the impact of higher manufacturing costs.

Marketing expense was $152.0 million, a $29.7 million increase. Marketing expense as a percentage of net sales increased 150 basis points to 10.1%.

Selling, general, and administrative expense (SG&A) was $230.0 million, including $7.3 million of charges related to restricted stock that was issued for the HERO acquisition. Adjusted SG&A was $222.71 million or 14.8% of net sales, an 80 basis points increase primarily due to investments in International and R&D.

Income from Operations was $305.0 million. Adjusted Income from Operations was $312.31 million, an increase of 4.4% inclusive of higher marketing and SG&A investments.

Other Expense decreased $2.2 million primarily due to lower outstanding debt and higher interest income.

The effective tax rate was 19.9% compared to 24.4% in 2023. The rate was lower due to a high level of stock option exercises in Q1 2024. The expected effective tax rate for the full year is unchanged at approximately 23%.

Operating Cash Flow

For the first three months of 2024, cash from operations was $263.0 million, a decrease of $10.1 million as higher cash earnings were offset by higher working capital. We now expect full year cash flow from operations to be approximately $1.05 billion (previously $1.0 billion). Capital expenditures for the first three months were $46.3 million, a $21.3 million increase from the prior year as capacity expansion projects proceed as planned.

At March 31, 2024, cash on hand was $349.7 million, while total debt was $2.2 billion.

2024 New Products

Mr. Farrell commented, “Product innovation continues to be a big driver of our success and we are excited about our new product launches. In 2024, we expect accelerated growth from new product launches as we lead with innovation in a number of key categories. Through the first few months of the year, we are encouraged by consumer enthusiasm for several of our new product introductions.

“ARM & HAMMER™ Laundry launched Deep Clean™ Liquid and Deep Clean Unit Dose Laundry Detergent. Arm & Hammer Deep Clean is our most premium Arm & Hammer laundry detergent, entering the mid-tier of the category and delivering a superior clean at a price consumers can afford.

“ARM & HAMMER™ launched Power Sheets™ Laundry Detergent online in August 2023. This innovative laundry solution is effective, convenient, and eliminates plastic bottle waste. ARM & HAMMER™ is the first major brand to offer a detergent sheet in the U.S. Due to its online success, Power Sheets™ is now available in select brick & mortar retailers.

“ARM & HAMMER™ Hardball™ Clumping Litter has expanded nationally after successful in-market testing in 2023. This transformational plant-based substrate is lightweight and creates virtually indestructible clumps for no-mess scooping. We expect this new litter to help ARM & HAMMER capture a greater share of the lightweight litter category.

“THERABREATH™, the #1 alcohol-free mouthwash brand, has entered the antiseptic segment of the category with the launch of TheraBreath™ Deep Clean Oral Rinse. Antiseptic mouthwashes account for 30% of the category. This product is formulated to kill 99.9% of germs that cause bad breath, plaque & gingivitis without the burn.

“BATISTE™, the global leader in dry shampoo, is meeting consumers’ desire for longer-lasting results with new BATISTE Sweat Activated and BATISTE Touch Activated dry shampoos. These breakthrough products are formulated with advanced technology and release a burst of fragrance whenever you sweat or touch your hair.

“HERO™ continues to drive the majority of growth in the acne category as the #1 patch brand in the U.S. In 2024, Hero will continue to launch innovative solutions in patches combined with adjacent products, such as Dissolve Away Daily Cleansing Balm, which will broaden our offerings of gentle and effective solutions for acne-prone skin.”

Outlook for 2024

Mr. Farrell stated, “We started the year with an exceptional quarter, delivering strong sales growth, gross margin expansion, and strong earnings growth. We remain confident about 2024 and will continue to focus on offering high quality products to consumers at the right value. We are thrilled with the early success of our new product launches.

“We continue to expect full year 2024 reported and organic sales growth to be approximately 4 to 5%.1

“We now expect full year gross margin to expand approximately 75 basis points versus 2023 (previously 50 to 75 basis points). We continue to expect an increase in manufacturing costs primarily due to capacity-related investments, third party manufacturing cost increases, and moderate commodity inflation. We continue to expect to more than offset these cost increases through carryover product pricing, mix, higher volume and productivity.

“We continue to invest behind our brands and are targeting marketing as a percentage of sales to be approximately 11%. SG&A is now expected to be flat as a percent of sales compared to 2023 (previously expected leverage) reflecting incremental infrastructure investments in International and ecommerce, and costs related to the Graphico acquisition.”

“Our full year reported EPS growth is expected to be approximately +9.5-10.5% and our Adjusted EPS growth expectation is now 8-9%1 (previously 7-9%), inclusive of a slightly dilutive EPS impact from the Graphico acquisition. We continue to expect our tax rate to be approximately 23%.

“Cash flow from operations is now expected to be approximately $1.05 billion (previously $1.0 billion), which would be an all-time high for the Company.

“This outlook reflects strong growth across all key measures, including reported and organic sales, volume, gross margin expansion, operating income growth and cash flow.

“We expect 2024 capital expenditures of approximately $180 million as we complete the major capacity investments that were initiated in 2023. We expect capital spending to return to historical levels (approximately 2% of sales) in 2025. Our capital allocation priorities remain unchanged and we will pursue accretive acquisitions that meet our strict criteria, with an emphasis on fast-moving consumable products, similar to our last 3 acquisitions (ZICAM, THERABREATH, and HERO).

“For Q2, we expect reported sales growth of approximately 3.5% and organic sales growth of approximately 4.0%¹ reflecting higher couponing in support of our new products. We expect moderate gross margin expansion, increased marketing spending to support our innovation pipeline, higher SG&A expense and a significantly higher tax rate (24%) compared to the prior year (17.9%) when our tax rate benefitted from a high level of stock option exercises. As a result, we expect reported EPS of $0.81 and Adjusted EPS of $0.83 per share, down 10% versus last year’s adjusted Q2 EPS.”¹

¹ Organic Sales, Adjusted SG&A, Adjusted Income from Operations and Adjusted EPS are non-GAAP measures. See non-GAAP reconciliations included at the end of this release.

Church & Dwight Co., Inc. (NYSE: CHD) will host a webcast to discuss first quarter 2024 results on May 2, 2024, at 10:00 a.m. (ET). The webcast will be broadcast online at investor.churchdwight.com/investors/news-events. It will also be available for replay from May 2, 2024 to May 9, 2024.

Church & Dwight Co., Inc. (NYSE: CHD) founded in 1846, is the leading U.S. producer of sodium bicarbonate, popularly known as baking soda. The Company manufactures and markets a wide range of personal care, household, and specialty products under recognized brand names such as ARM & HAMMER®, TROJAN®, OXICLEAN®, SPINBRUSH®, FIRST RESPONSE®, NAIR®, ORAJEL®, XTRA®, L’IL CRITTERS® and VITAFUSION®, BATISTE®, WATERPIK®, ZICAM®, THERABREATH® and HERO®. For more information, visit the Company’s website.

Church & Dwight has a heritage of commitment to people and the planet. In the early 1900’s, we began using recycled paperboard for all packaging of household products. Today, virtually all our paperboard packaging is from certified, sustainable sources. In 1970, the ARM & HAMMER brand introduced the first nationally distributed, phosphate-free detergent. That same year, Church & Dwight was honored to be the sole corporate sponsor of the first annual Earth Day. In 2023, our continued progress earned continued public recognition, including the Newsweek Magazine’s Americas Most Responsible and America’s Greenest Companies lists, the EPA’s Green Power Partnership-Top 100 list, the 2023 Wall Street Journal Management Top 250 List, the 2022/2023 Forbes Magazine: Americas Best Midsize Employer Award and the FTSE4Good Index Series, amongst others.

For more information, see the Church & Dwight 2023 Sustainability Report at: https://churchdwight.com/pdf/Sustainability/2023-Sustainability-Report.pdf

This press release contains forward-looking statements, including, among others, statements relating to net sales and earnings growth; gross margin changes; trade, marketing, and SG&A spending; recessionary conditions; interest rates; inflation; sufficiency of cash flows from operations; earnings per share; cost savings programs; consumer demand and spending; the effects of competition; the effect of product mix; volume growth, including the effects of new product launches into new and existing categories; the impact of acquisitions (including earn-outs); and capital expenditures. Other forward-looking statements in this release may be identified by the use of such terms as “may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate,” “to be,” “to make” or other comparable terms. These statements represent the intentions, plans, expectations and beliefs of the Company, and are based on assumptions that the Company believes are reasonable but may prove to be incorrect. In addition, these statements are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that could cause such differences include a decline in market growth, retailer distribution and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events), including those relating to the outbreak of contagious diseases; other impacts of the COVID-19 pandemic and its impact on the Company’s operations, customers, suppliers, employees, and other constituents, and market volatility and impact on the economy (including contributions to recessionary conditions), resulting from global, nationwide or local or regional outbreaks or increases in infections, new variants, and the risk that the Company will not be able to successfully execute its response plans with respect to the pandemic or localized outbreaks and the corresponding uncertainty; the impact of new legislation such as the U.S. CARES Act, the EU Medical Device Regulation, new cosmetic and device regulations in Mexico, and the U.S. Modernization of Cosmetic Regulation Act; the impact on the global economy of the Russia/Ukraine war and increased conflict in the Middle East, including the impact of export controls and other economic sanctions; potential recessionary conditions or economic uncertainty; the impact of continued shifts in consumer behavior, including accelerating shifts to on-line shopping; unanticipated increases in raw material and energy prices, including as a result of the Russia/Ukraine war, increased conflict in the Middle East or other inflationary pressures; delays and increased costs in manufacturing and distribution; increases in transportation costs; labor shortages; the impact of price increases for our products; the impact of inflationary conditions; the impact of supply chain and labor disruptions; the impact of severe or inclement weather on raw material and transportation costs; adverse developments affecting the financial condition of major customers and suppliers; competition; changes in marketing and promotional spending; growth or declines in various product categories and the impact of customer actions in response to changes in consumer demand and the economy, including increasing shelf space or on-line share of private label and retailer-branded products or other changes in the retail environment; consumer and competitor reaction to, and customer acceptance of, new product introductions and features; the Company’s ability to maintain product quality and characteristics at a level acceptable to our customers and consumers; disruptions in the banking system and financial markets; the Company’s borrowing capacity and ability to finance its operations and potential acquisitions; higher interest rates; foreign currency exchange rate fluctuations; transition to, and shifting economic policies in the United States; potential changes in export/import and trade laws, regulations and policies of the United States and other countries, including any increased trade restrictions or tariffs; increased or changing regulation regarding the Company’s products and its suppliers in the United States and other countries where it or its suppliers operate; market volatility; issues relating to the Company’s information technology and controls; the impact of natural disasters, including those related to climate change, on the Company and its customers and suppliers, including third party information technology service providers; integrations of acquisitions or divestiture of assets; the outcome of contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the regulatory environment in the countries where we do business.

For a description of additional factors that could cause actual results to differ materially from the forward-looking statements, please see Item 1A, “Risk Factors” in the Company’s annual report on Form 10-K and quarterly reports on Form 10-Q. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the U.S. federal securities laws. You are advised, however, to consult any further disclosures the Company makes on related subjects in its filings with the United States Securities and Exchange Commission.

This press release also contains non-GAAP financial information. Management uses this information in its internal analysis of results and believes that this information may be informative to investors in gauging the quality of the Company’s financial performance, identifying trends in its results and providing meaningful period-to-period comparisons. The Company has included reconciliations of these non-GAAP financial measures to the most directly comparable financial measure calculated in accordance with GAAP. See the end of this press release for these reconciliations. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP financial measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. They should be read in connection with the Company’s financial statements presented in accordance with GAAP.

CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Income (Unaudited)

 

 

 

Three Months Ended

 

(In millions, except per share data)

 

March 31, 2024

 

 

March 31, 2023

 

Net Sales

 

$

1,503.3

 

 

$

1,429.8

 

Cost of sales

 

 

816.3

 

 

 

807.8

 

Gross Profit

 

 

687.0

 

 

 

622.0

 

Marketing expenses

 

 

152.0

 

 

 

122.3

 

Selling, general and administrative expenses

 

 

230.0

 

 

 

207.8

 

Income from Operations

 

 

305.0

 

 

 

291.9

 

Equity in earnings of affiliates

 

 

1.1

 

 

 

4.4

 

Other income (expense), net

 

 

(22.0

)

 

 

(27.5

)

Income before Income Taxes

 

 

284.1

 

 

 

268.8

 

Income taxes

 

 

56.4

 

 

 

65.6

 

Net Income

 

$

227.7

 

 

$

203.2

 

Net Income per share - Basic

 

$

0.94

 

 

$

0.83

 

Net Income per share - Diluted

 

$

0.93

 

 

$

0.82

 

Dividends per share

 

$

0.28

 

 

$

0.27

 

Weighted average shares outstanding - Basic

 

 

243.4

 

 

 

243.8

 

Weighted average shares outstanding - Diluted

 

 

246.1

 

 

 

246.8

 

 

CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets (Unaudited)

 

(Dollars in millions)

 

March 31, 2024

 

 

December 31, 2023

 

Assets

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

Cash and Cash Equivalents

 

$

349.7

 

 

$

344.5

 

Accounts Receivable

 

 

545.4

 

 

 

526.9

 

Inventories

 

 

595.4

 

 

 

613.3

 

Other Current Assets

 

 

43.8

 

 

 

45.0

 

Total Current Assets

 

 

1,534.3

 

 

 

1,529.7

 

Property, Plant and Equipment (Net)

 

 

939.2

 

 

 

927.7

 

Equity Investment in Affiliates

 

 

12.3

 

 

 

12.0

 

Trade Names and Other Intangibles

 

 

3,271.1

 

 

 

3,302.3

 

Goodwill

 

 

2,431.5

 

 

 

2,431.5

 

Other Long-Term Assets

 

 

373.1

 

 

 

366.0

 

Total Assets

 

$

8,561.5

 

 

$

8,569.2

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

Short-Term Debt

 

$

4.0

 

 

$

3.9

 

Current portion of Long-Term debt

 

0.0

 

 

 

199.9

 

Other Current Liabilities

 

 

1,147.1

 

 

 

1,218.2

 

Total Current Liabilities

 

 

1,151.1

 

 

 

1,422.0

 

Long-Term Debt

 

 

2,202.8

 

 

 

2,202.2

 

Other Long-Term Liabilities

 

 

1,106.9

 

 

 

1,089.6

 

Stockholders’ Equity

 

 

4,100.7

 

 

 

3,855.4

 

Total Liabilities and Stockholders’ Equity

 

$

8,561.5

 

 

$

8,569.2

 

 

CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flow (Unaudited)

 

 

 

Three Months Ended

 

(Dollars in millions)

 

March 31, 2024

 

 

March 31, 2023

 

 

 

 

 

 

 

 

Net Income

 

$

227.7

 

 

$

203.2

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

57.6

 

 

 

54.9

 

Deferred income taxes

 

 

(1.2

)

 

 

(1.6

)

Non-cash compensation

 

 

28.9

 

 

 

25.8

 

Other

 

 

2.4

 

 

 

(0.1

)

Subtotal

 

 

315.4

 

 

 

282.2

 

 

 

 

 

 

 

 

Changes in assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(20.0

)

 

 

(2.4

)

Inventories

 

 

16.1

 

 

 

(4.8

)

Other current assets

 

 

(5.2

)

 

 

0.7

 

Accounts payable

 

 

31.4

 

 

 

(19.7

)

Accrued expenses

 

 

(118.7

)

 

 

(42.3

)

Income taxes payable

 

 

46.6

 

 

 

57.7

 

Other

 

 

(2.6

)

 

 

1.7

 

Net cash from operating activities

 

 

263.0

 

 

 

273.1

 

 

 

 

 

 

 

 

Capital expenditures

 

 

(46.3

)

 

 

(25.0

)

Other

 

 

(0.5

)

 

 

(4.6

)

Net cash (used in) investing activities

 

 

(46.8

)

 

 

(29.6

)

 

 

 

 

 

 

 

Net change in long-term debt

 

 

(200.0

)

 

 

(200.0

)

Net change in short-term debt

 

0.0

 

 

 

(55.6

)

Payment of cash dividends

 

 

(69.0

)

 

 

(66.3

)

Proceeds from stock option exercises

 

 

59.9

 

 

 

10.2

 

Net cash (used in) financing activities

 

 

(209.1

)

 

 

(311.7

)

 

 

 

 

 

 

 

F/X impact on cash

 

 

(1.9

)

 

 

0.7

 

 

 

 

 

 

 

 

Net change in cash and cash equivalents

 

$

5.2

 

 

$

(67.5

)

 

2024 and 2023 Product Line Net Sales

 

 

Three Months Ended

 

 

Percent

 

 

3/31/2024

 

 

3/31/2023

 

 

Change

 

Household Products

$

638.9

 

 

$

601.6

 

 

 

6.2

%

Personal Care Products

 

526.3

 

 

 

515.3

 

 

 

2.1

%

Consumer Domestic

$

1,165.2

 

 

$

1,116.9

 

 

 

4.3

%

Consumer International

 

255.0

 

 

 

230.6

 

 

 

10.6

%

Total Consumer Net Sales

$

1,420.2

 

 

$

1,347.5

 

 

 

5.4

%

Specialty Products Division

 

83.1

 

 

 

82.3

 

 

 

1.0

%

Total Net Sales

$

1,503.3

 

 

$

1,429.8

 

 

 

5.1

%

 

 

 

 

 

 

 

 

 

Non-GAAP Measures:

The following discussion addresses the non-GAAP measures used in this press release and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures. These non-GAAP financial measures should not be considered in isolation from or as a substitute for the comparable GAAP measures. The following non-GAAP measures may not be the same as similar measures provided by other companies due to differences in methods of calculation and items and events being excluded.

Organic Sales Growth:

This press release provides information regarding organic sales growth, namely net sales growth excluding the effect of acquisitions, divestitures and foreign exchange rate changes. Management believes that the presentation of organic sales growth is useful to investors because it enables them to assess, on a consistent basis, sales trends related to products that were marketed by the Company during the entirety of relevant periods, excluding the impact of acquisitions, divestitures, and foreign exchange rate changes that are out of the control of, and do not reflect the performance of the Company and management.

Adjusted Selling, General, and Administrative Expense (SG&A):

This press release also presents adjusted SG&A, namely, SG&A calculated in accordance with GAAP, as adjusted to exclude significant one-time items that are not indicative of the Company’s period-to-period performance. We believe that this metric provides investors a useful perspective of underlying business trends and results and provides useful supplemental information regarding our year over year SG&A expense.

Adjusted Income from Operations:

This press release also presents adjusted income from operations, namely income from operations calculated in accordance with GAAP, as adjusted to exclude significant one-time items that are not indicative of the Company’s period-to-period performance. We believe that this metric provides investors a useful perspective of underlying business trends and results and provides useful supplemental information regarding our year over year income from operations.

Adjusted EPS:

This press release also presents adjusted earnings per share, namely, EPS calculated in accordance with GAAP, as adjusted to exclude significant one-time items that are not indicative of the Company’s period-to-period performance. We believe that this metric provides investors a useful perspective of underlying business trends and results and provides useful supplemental information regarding our year over year EPS growth.

Adjusted Effective Tax Rate:

This press release also presents an adjusted effective tax rate, namely, the effective tax rate calculated in accordance with GAAP, as adjusted to exclude significant one-time items that are not indicative of the Company’s period-to-period performance. We believe that this metric provides investors a useful perspective of underlying business trends and results and provides useful supplemental information regarding our effective tax rate.

CHURCH & DWIGHT CO., INC.

Organic Sales

 

 

Three Months Ended 3/31/2024

 

 

 

 

 

 

 

 

 

 

 

Total

 

Worldwide

 

Consumer

 

Consumer

 

Specialty

 

Company

 

Consumer

 

Domestic

 

International

 

Products

Reported Sales Growth

5.1%

 

5.4%

 

4.3%

 

10.6%

 

1.0%

Less:

 

 

 

 

 

 

 

 

 

Acquisitions

0.0%

 

0.0%

 

0.0%

 

0.0%

 

0.0%

Add:

 

 

 

 

 

 

 

 

 

FX / Other

-0.3%

 

-0.3%

 

0.0%

 

-1.8%

 

0.0%

Divestitures

0.4%

 

0.0%

 

0.0%

 

0.0%

 

6.2%

 

 

 

 

 

 

 

 

 

 

Organic Sales Growth

5.2%

 

5.1%

 

4.3%

 

8.8%

 

7.2%

 

 

 

 

 

 

 

 

 

 

CHURCH & DWIGHT CO., INC.

Reconciliation of GAAP Measures to Non-GAAP Measures (Unaudited)

 

(Dollars in millions, except per share data)

 

For the quarter ended

March 31, 2024

 

 

For the quarter ended

March 31, 2023

 

 

Change

 

 

 

 

% of NS

 

 

 

 

 

% of NS

 

 

 

 

 

Adjusted SG&A Reconciliation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SG&A - Reported

$

230.0

 

 

 

15.3

%

 

$

207.8

 

 

 

14.5

%

 

 

80

 

bps

Hero Restricted Stock

 

(7.3

)

 

 

-0.5

%

 

 

(7.3

)

 

 

-0.5

%

 

 

0

 

bps

SG&A - Adjusted (non-GAAP)

$

222.7

 

 

 

14.8

%

 

$

200.5

 

 

 

14.0

%

 

 

80

 

bps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the quarter ended

March 31, 2024

 

 

For the quarter ended

March 31, 2023

 

 

Change

Adjusted Income From Operations

 

 

 

% of NS

 

 

 

 

 

% of NS

 

 

 

 

 

Income From Operations - Reported

$

305.0

 

 

 

20.3

%

 

$

291.9

 

 

 

20.4

%

 

 

-10

 

bps

Hero Restricted Stock

 

7.3

 

 

 

0.5

%

 

 

7.3

 

 

 

0.5

%

 

 

0

 

bps

Income From Operations - Adjusted (non-GAAP)

$

312.3

 

 

 

20.8

%

 

$

299.2

 

 

 

20.9

%

 

 

-10

 

bps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the quarter ended

March 31, 2024

 

 

For the quarter ended

March 31, 2023

 

 

Change

Adjusted Diluted Earnings Per Share Reconciliation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted Earnings Per Share - Reported

$

0.93

 

 

 

 

 

$

0.82

 

 

 

 

 

 

13.4

%

 

Hero Restricted Stock

 

0.03

 

 

 

 

 

 

0.03

 

 

 

 

 

 

 

 

Diluted Earnings Per Share - Adjusted (non-GAAP)

$

0.96

 

 

 

 

 

$

0.85

 

 

 

 

 

 

12.9

%

 

Reported and Organic Forecasted Sales Reconciliation

 

 

 

 

 

For the Quarter

 

For the Year

 

Ended

 

Ended

 

30-Jun-24

 

31-Dec-24

Reported Sales Growth

3.5%

 

4.5%

Megalac

0.7%

 

0.5%

FX / Other

-0.2%

 

-0.3%

 

 

 

 

Organic Sales Growth

4.0%

 

4.7%

Reported and Adjusted Diluted Earnings Per Share - Outlook

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the quarter ended

June 30, 2024

 

 

For the quarter ended

June 30, 2023

 

 

Change

Adjusted Diluted Earnings Per Share Reconciliation (Forecasted)

 

 

 

 

 

 

 

 

 

Diluted Earnings Per Share - Reported

$

0.81

 

 

$

0.89

 

 

 

-9.0

%

 

Hero Restricted Stock

 

0.02

 

 

 

0.03

 

 

 

 

 

Diluted Earnings Per Share - Adjusted (non-GAAP)

$

0.83

 

 

$

0.92

 

 

 

-9.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the year ended

December 31, 2024

 

 

For the year ended

December 31, 2023

 

 

Change

Adjusted Diluted Earnings Per Share Reconciliation (Forecasted)

 

 

 

 

 

 

 

 

 

Diluted Earnings Per Share - Reported

$

3.34 to 3.37

 

 

$

3.05

 

 

9.5% to 10.5%

 

 

Hero Restricted Stock

 

0.08

 

 

 

0.12

 

 

 

 

 

Diluted Earnings Per Share - Adjusted (non-GAAP)

$

3.42 to 3.45

 

 

$

3.17

 

 

8% to 9%

 

 

 

Contacts

Rick Dierker

Chief Financial Officer

609-806-1200

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.